DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

How Far Will Health Plan Consolidation Transform the Value Chain?

The MCO market is undergoing unprecedented consolidation with far-reaching effects for the Life Sciences industry.

  • It may very well be that the health plan industry is shifting away from contracting with stand-alone PBMs back to MCOs controlling their own pharmacy management.
  • Many impacts on Medicare Part D market, Medicaid market, Medicare Advantage Market, geographies, public healthcare exchanges, benefit design, and alternative contracting models.